Updated clinical practice recommendations for managing children with 22q11.2 deletion syndrome
Genetics in Medicine · 2023-03 · 25 (3) · 100338
DOI: 10.1016/j.gim.2022.11.006 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Genetics in Medicine, 2023-03. Verfasst von Sólveig Óskarsdóttir und 39 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Rheumatology and Immunology, Queen Silvia Children's Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden; Departmen…. Hauptthemen laut MEDLINE: DiGeorge Syndrome. Die Arbeit wurde bisher 101-mal zitiert (Crossref) und nennt 265 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Toronto.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
This review aimed to update the clinical practice guidelines for managing children and adolescents with 22q11.2 deletion syndrome (22q11.2DS). The 22q11.2 Society, the international scientific organization studying chromosome 22q11.2 differences and related conditions, recruited expert clinicians worldwide to revise the original 2011 pediatric clinical practice guidelines in a stepwise process: (1) a systematic literature search (1992-2021), (2) study selection and data extraction by clinical experts from 9 different countries, covering 24 subspecialties, and (3) creation of a draft consensus document based on the literature and expert opinion, which was further shaped by survey results from family support organizations regarding perceived needs. Of 2441 22q11.2DS-relevant publications initially identified, 2344 received full-text reviews, including 1545 meeting criteria for potential relevance to clinical care of children and adolescents. Informed by the available literature, recommendations were formulated. Given evidence base limitations, multidisciplinary recommendations represent consensus statements of good practice for this evolving field. These recommendations provide contemporary guidance for evaluation, surveillance, and management of the many 22q11.2DS-associated physical, cognitive, behavioral, and psychiatric morbidities while addressing important genetic counseling and psychosocial issues.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Rheumatology and Immunology, Queen Silvia Children's Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden; Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy,…
- Advisium, 's Heeren Loo Zorggroep, Amersfoort, The Netherlands; The Dalglish Family 22q Clinic, University Health Network, Toronto, Ontario, Canada; Department of Psychiatry and Neuropsychology, Maastricht University, M…
- The 22q and You Center, Clinical Genetics Center, and Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, PA.
- The Dalglish Family 22q Clinic, University Health Network, Toronto, Ontario, Canada.
- Department of Otorhinolaryngology, Children's Mercy Hospital and University of Missouri Kansas City School of Medicine, Kansas City, MO.
- Division of Child and Adolescent Psychiatry, Department of Psychiatry, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Förderung
- University of Toronto
Zitieren
APA
Óskarsdóttir, S., Boot, E., Crowley, T. B., Loo, J. C. Y., Arganbright, J. M., Armando, M., Baylis, A. L., Breetvelt, E. J., Castelein, R. M., Chadehumbe, M., Cielo, C. M., de Reuver, S., Eliez, S., Fiksinski, A. M., Forbes, B. J., Gallagher, E., Hopkins, S. E., Jackson, O. A., Levitz-Katz, L., …, & McDonald-McGinn, D. M. (2023). Updated clinical practice recommendations for managing children with 22q11.2 deletion syndrome. Genetics in Medicine, 25(3), 100338. https://doi.org/10.1016/j.gim.2022.11.006
Vancouver
Óskarsdóttir S, Boot E, Crowley TB, Loo JCY, Arganbright JM, Armando M, et al. Updated clinical practice recommendations for managing children with 22q11.2 deletion syndrome. Genetics in Medicine. 2023;25(3):100338. doi:10.1016/j.gim.2022.11.006
BibTeX
@article{skarsdttir2023,
author = {Óskarsdóttir, Sólveig and Boot, Erik and Crowley, Terrence Blaine and Loo, Joanne C Y and Arganbright, Jill M and Armando, Marco and Baylis, Adriane L and Breetvelt, Elemi J and Castelein, René M and Chadehumbe, Madeline and Cielo, Christopher M and de Reuver, Steven and Eliez, Stephan and Fiksinski, Ania M and Forbes, Brian J and Gallagher, Emily and Hopkins, Sarah E and Jackson, Oksana A and Levitz-Katz, Lorraine and Klingberg, Gunilla and Lambert, Michele P and Marino, Bruno and Mascarenhas, Maria R and Moldenhauer, Julie and Moss, Edward M and Nowakowska, Beata Anna and Orchanian-Cheff, Ani and Putotto, Carolina and Repetto, Gabriela M and Schindewolf, Erica and Schneider, Maude and Solot, Cynthia B and Sullivan, Kathleen E and Swillen, Ann and Unolt, Marta and Van Batavia, Jason P and Vingerhoets, Claudia and Vorstman, Jacob and Bassett, Anne S and McDonald-McGinn, Donna M},
title = {Updated clinical practice recommendations for managing children with 22q11.2 deletion syndrome},
journal = {Genetics in Medicine},
year = {2023},
volume = {25},
number = {3},
pages = {100338},
doi = {10.1016/j.gim.2022.11.006}
}
EUVIMED